Marat Vitalyevich Kurmyshev
Research Subjects
Marat Vitalyevich Kurmyshev has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Georgiy Petrovich Kostyuk
Lomonosov Moscow State University
10 shared publications - Alisa. V. Andryushchenko
Psychiatric Hospital no. 1 named after N.A. Alexeev of the Department of Health of Moscow
8 shared publications - Olga Anatolyevna Karpenko
Mental-health clinic No. 1 named after N.A. Alexeev
8 shared publications - Timur Sergeevich Syunyakov
Samara State Medical University
8 shared publications - Anna Morozova
V. Serbsky National Medical Research Centre of Psychiatry and Narcology, 119034 Moscow, Russia
7 shared publications - Olga Abramova
V. Serbsky National Medical Research Centre of Psychiatry and Narcology, 119034 Moscow, Russia
7 shared publications
Latest Publications
- 29 April 2026
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 126 (4) , 47-55
Transitional cognitive syndrome: Reconsidered classification of cognitive disorders
Objective. To assess the prevalence of the transitional cognitive syndrome (TCS) and evaluate the effectiveness of neurocognitive training in elderly individuals presenting with cognitive symptoms. Material and methods. The study enrolled 198 elderly individuals with cognitive impairment symptoms from the Memory Clinics of the Moscow Department of Health and the N.A. Alekseev Psychiatric Clinical Hospital No. 1. Of these, 111 participants were assigned to the intervention group and received neurocognitive training (rehabilitation), while 87 participants formed the comparison group and received follow-up only. Neuropsychological assessments were conducted at baseline and after 12 months of follow-up. Results. In this sample, TCS accounted for approximately 5% of all cognitive impairments and remained stable over the one-year follow-up period. Annually, about 7% of mild cognitive impairment cases progressed to TCS, while 11—16% of TCS cases advanced to more severe dementia, irrespective of neurorehabilitation. These findings suggest the presence of an active neurodegenerative process. Neurorehabilitation was effective in improving regulatory functions, including among elderly participants. Conclusion. The introduction of the TCS concept allows for more precise classification of patients at the transitional stage between mild cognitive impairment and dementia. This framework improves risk assessment for short-term progression to more severe cognitive impairment and provides clinical justification for pathogenetic therapy, including the use of Miladean. The TCS concept also supports patient management and reduces the stigma associated with diagnosis at this stage, which is significant for both patients and their families. Advanced age and concomitant diabetes mellitus were identified as the most significant adverse factors for cognitive impairment. The observed effectiveness of neurocognitive rehabilitation in patients aged 75 years and older indicates that rehabilitation should not be limited by age.
- 29 April 2026
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 126 (4) , 47-55
Transitional cognitive syndrome: Reconsidered classification of cognitive disorders
Objective. To assess the prevalence of the transitional cognitive syndrome (TCS) and evaluate the effectiveness of neurocognitive training in elderly individuals presenting with cognitive symptoms. Material and methods. The study enrolled 198 elderly individuals with cognitive impairment symptoms from the Memory Clinics of the Moscow Department of Health and the N.A. Alekseev Psychiatric Clinical Hospital No. 1. Of these, 111 participants were assigned to the intervention group and received neurocognitive training (rehabilitation), while 87 participants formed the comparison group and received follow-up only. Neuropsychological assessments were conducted at baseline and after 12 months of follow-up. Results. In this sample, TCS accounted for approximately 5% of all cognitive impairments and remained stable over the one-year follow-up period. Annually, about 7% of mild cognitive impairment cases progressed to TCS, while 11—16% of TCS cases advanced to more severe dementia, irrespective of neurorehabilitation. These findings suggest the presence of an active neurodegenerative process. Neurorehabilitation was effective in improving regulatory functions, including among elderly participants. Conclusion. The introduction of the TCS concept allows for more precise classification of patients at the transitional stage between mild cognitive impairment and dementia. This framework improves risk assessment for short-term progression to more severe cognitive impairment and provides clinical justification for pathogenetic therapy, including the use of Miladean. The TCS concept also supports patient management and reduces the stigma associated with diagnosis at this stage, which is significant for both patients and their families. Advanced age and concomitant diabetes mellitus were identified as the most significant adverse factors for cognitive impairment. The observed effectiveness of neurocognitive rehabilitation in patients aged 75 years and older indicates that rehabilitation should not be limited by age.
- Open Access
- 11 January 2026
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 22,p. 152-162
Diagnostic potential of electroencephalogram analysis methods in Alzheimer’s disease: A narrative review
This review focuses on the application of electroencephalography for the early diagnosis of Alzheimer’s disease and assesses its potential as an accessible screening tool for cognitive impairment. The objective of this work is to summarize and analyze existing approaches to the application of electroencephalography methods for the diagnosis and monitoring of Alzheimer’s disease, as well as to identify key features of bioelectrical activity associated with cognitive impairment in AD compared to normal aging processes. The review examined 64 original studies (1998–2024) focused on the diagnosis of Alzheimer’s disease using electroencephalography, primarily employing spectral analysis, coherence analysis, event-related potentials, and graph theory. Data synthesis was performed using a descriptive method. Collectively, contemporary methods for analyzing electroencephalographic data demonstrate significant potential for identifying neurophysiological markers of Alzheimer’s disease. Specifically, spectral analysis reveals an increase in delta and theta rhythm power alongside a decrease in alpha activity and individual alpha frequency, reflecting neurodegenerative processes and impaired cognitive regulation. Coherence analysis indicates a disintegration of functional connections between cortical regions, manifested as reduced coherence in the alpha and beta bands and a compensatory increase in slow rhythms. Event-related potential analysis, particularly of the P300 and N400 components, points to slowed information processing and reduced efficiency of cognitive mechanisms. Graph theory methods, specifically small-world network analysis, complement this picture by demonstrating a disrupted balance between local specialization and global integration of neural networks. In turn, the application of machine learning algorithms based on these metrics opens avenues for enhancing diagnostic accuracy, predicting the progression of cognitive impairment, and developing automated systems for the early detection of Alzheimer’s disease. Quantitative electroencephalography analysis methods hold considerable promise for the early screening of Alzheimer’s disease by revealing characteristic patterns of brain activity. But for the effective utilization of EEG, the standardization of recording protocols, unification of analytical methods, and integration with machine learning algorithms are essential.
- 11 January 2026
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 22,p. 152-162
Open AccessDiagnostic potential of electroencephalogram analysis methods in Alzheimer’s disease: A narrative review
This review focuses on the application of electroencephalography for the early diagnosis of Alzheimer’s disease and assesses its potential as an accessible screening tool for cognitive impairment. The objective of this work is to summarize and analyze existing approaches to the application of electroencephalography methods for the diagnosis and monitoring of Alzheimer’s disease, as well as to identify key features of bioelectrical activity associated with cognitive impairment in AD compared to normal aging processes. The review examined 64 original studies (1998–2024) focused on the diagnosis of Alzheimer’s disease using electroencephalography, primarily employing spectral analysis, coherence analysis, event-related potentials, and graph theory. Data synthesis was performed using a descriptive method. Collectively, contemporary methods for analyzing electroencephalographic data demonstrate significant potential for identifying neurophysiological markers of Alzheimer’s disease. Specifically, spectral analysis reveals an increase in delta and theta rhythm power alongside a decrease in alpha activity and individual alpha frequency, reflecting neurodegenerative processes and impaired cognitive regulation. Coherence analysis indicates a disintegration of functional connections between cortical regions, manifested as reduced coherence in the alpha and beta bands and a compensatory increase in slow rhythms. Event-related potential analysis, particularly of the P300 and N400 components, points to slowed information processing and reduced efficiency of cognitive mechanisms. Graph theory methods, specifically small-world network analysis, complement this picture by demonstrating a disrupted balance between local specialization and global integration of neural networks. In turn, the application of machine learning algorithms based on these metrics opens avenues for enhancing diagnostic accuracy, predicting the progression of cognitive impairment, and developing automated systems for the early detection of Alzheimer’s disease. Quantitative electroencephalography analysis methods hold considerable promise for the early screening of Alzheimer’s disease by revealing characteristic patterns of brain activity. But for the effective utilization of EEG, the standardization of recording protocols, unification of analytical methods, and integration with machine learning algorithms are essential.
- Open Access
- 3 June 2025
- Published by MDPI AG in Psychiatry International
- Vol. 6 (2) , 64
Dynamics of Cognitive Impairment in Older Adults Linked to Suicide-Related Single-Nucleotide Polymorphisms: A 3-Year Follow-Up Study
Background: Cognitive decline during aging is a factor that inevitably affects everyone. In some older adults, cognitive function declines more rapidly to mild cognitive impairment (MCI) and eventually dementia. Our work aimed to determine the associations between suicide-related single-nucleotide genetic polymorphisms (SNPs) and cognitive function dynamics in people over 65 years old over a three-year follow-up. Suicide-related SNPs have already shown an association with dementia in our previous study. Methods: The present study included 66 participants over 65 without subjective cognitive decline. Cognitive impairment was assessed at two follow-up points (at the start of the study in 2020–2021 and 3 years later) using the Montreal Cognitive Assessment (MoCA). Patients were also genotyped for 16 SNPs. Results: We found associations between rs10898553 and rs165774 and MoCA 3-year dynamics, with a certain genetic variant related to more significant progression. For rs7982251, associations with scale scores were found, but no effect on its dynamics. Conclusions: The research focused on analyzing genetic factors of cognitive decline in healthy older adults without subjective cognitive decline. Identifying these markers can help predict the development of pathology at early stages and start timely treatment.
- 3 June 2025
- Published by MDPI AG in Psychiatry International
- Vol. 6 (2) , 64
Open AccessDynamics of Cognitive Impairment in Older Adults Linked to Suicide-Related Single-Nucleotide Polymorphisms: A 3-Year Follow-Up Study
Background: Cognitive decline during aging is a factor that inevitably affects everyone. In some older adults, cognitive function declines more rapidly to mild cognitive impairment (MCI) and eventually dementia. Our work aimed to determine the associations between suicide-related single-nucleotide genetic polymorphisms (SNPs) and cognitive function dynamics in people over 65 years old over a three-year follow-up. Suicide-related SNPs have already shown an association with dementia in our previous study. Methods: The present study included 66 participants over 65 without subjective cognitive decline. Cognitive impairment was assessed at two follow-up points (at the start of the study in 2020–2021 and 3 years later) using the Montreal Cognitive Assessment (MoCA). Patients were also genotyped for 16 SNPs. Results: We found associations between rs10898553 and rs165774 and MoCA 3-year dynamics, with a certain genetic variant related to more significant progression. For rs7982251, associations with scale scores were found, but no effect on its dynamics. Conclusions: The research focused on analyzing genetic factors of cognitive decline in healthy older adults without subjective cognitive decline. Identifying these markers can help predict the development of pathology at early stages and start timely treatment.
- 10 December 2024
- Published by Springer Nature
- p. 184-191
Identification of Cognitive Deficits Based on T1-Weighted Magnetic Resonance Imaging
- 10 December 2024
- Published by Springer Nature
- p. 184-191
Identification of Cognitive Deficits Based on T1-Weighted Magnetic Resonance Imaging
- Open Access
- 28 August 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (17) , 1883
Dynamics of Cognitive Impairment in MCI Patients over a Three-Year Period: The Informative Role of Blood Biomarkers, Neuroimaging, and Genetic Factors
Given the high growth rates of cognitive decline among the elderly population and the lack of effective etiological treatments, early diagnosis of cognitive impairment progression is an imperative task for modern science and medicine. It is of particular interest to identify predictors of an unfavorable subsequent course of cognitive disorders, specifically, rapid progression. Our study assessed the informative role of various risk factors on the dynamics of cognitive impairment among mild cognitive impairment (MCI) patients. The study included patients with MCI (N = 338) who underwent neuropsychological assessment, magnetic resonance imaging (MRI) examination, blood sampling for general and biochemical analysis, APOE genotyping, and polygenic risk score (PRS) evaluation. The APOE ε4/ε4 genotype was found to be associated with a diminished overall cognitive scores initial assessment and negative cognitive dynamics. No associations were found between cognitive changes and the PRS. The progression of cognitive impairment was associated with the width of the third ventricle and hematological parameters, specifically, hematocrit and erythrocyte levels. The absence of significant associations between the dynamics of cognitive decline and PRS over three years can be attributed to the provided suitable medical care for the prevention of cognitive impairment. Adding other risk factors and their inclusion in panels assessing the risk of progression of cognitive impairment should be considered.
- 28 August 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (17) , 1883
Open AccessDynamics of Cognitive Impairment in MCI Patients over a Three-Year Period: The Informative Role of Blood Biomarkers, Neuroimaging, and Genetic Factors
Given the high growth rates of cognitive decline among the elderly population and the lack of effective etiological treatments, early diagnosis of cognitive impairment progression is an imperative task for modern science and medicine. It is of particular interest to identify predictors of an unfavorable subsequent course of cognitive disorders, specifically, rapid progression. Our study assessed the informative role of various risk factors on the dynamics of cognitive impairment among mild cognitive impairment (MCI) patients. The study included patients with MCI (N = 338) who underwent neuropsychological assessment, magnetic resonance imaging (MRI) examination, blood sampling for general and biochemical analysis, APOE genotyping, and polygenic risk score (PRS) evaluation. The APOE ε4/ε4 genotype was found to be associated with a diminished overall cognitive scores initial assessment and negative cognitive dynamics. No associations were found between cognitive changes and the PRS. The progression of cognitive impairment was associated with the width of the third ventricle and hematological parameters, specifically, hematocrit and erythrocyte levels. The absence of significant associations between the dynamics of cognitive decline and PRS over three years can be attributed to the provided suitable medical care for the prevention of cognitive impairment. Adding other risk factors and their inclusion in panels assessing the risk of progression of cognitive impairment should be considered.
- 23 April 2024
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 124 (8) , 81-91
Immunological and neuroanatomic markers of the clinical dynamics of MCI and pre-MCI
Objective. To study the relationship of the parameters of immunity and systemic inflammation with the structural magnetic resonance imaging (MRI) parameters in patients with mild cognitive impairment (MCI) and pre-MCI undergoing neurocognitive rehabilitation to search for candidate markers of its effectiveness. Material and methods. The main group included 49 patients, aged ≥60 years, with MCI and pre-MCI with memory impairment, who underwent a course of neurorehabilitation for 5 weeks. The control group included 19 volunteers of similar age with a total MoCA score of ≥25, who did not have cognitive impairment and immuno-inflammatory disorders. The parameters of cellular and humoral immunity and markers of inflammation were studied, and structural MRI was performed. Results. The content of activated natural killer cells (NK-cells) was increased in MCI and pre-MCI (0.63±0.12% vs. 0.22±0.07% in the control group, p=2.2·10–7). The level of immunoglobulin G (IgG) <12.5 g/l in patients with MCI and pre-MCI with the Montreal Cognitive Assessment Scale (MoCA) score <22 was associated with a decrease in the volume of the right nucleus accumbens (376±35 mm3 in patients with IgG <12.5 g/l (p=0.0013) and 480±44 mm3 at IgG <12.5 g/l, 480±44 mm3 in the control group), as well as with a decrease of the thickness and volume of a number of other cortical zones. A logistic regression model including the level of immunoglobulin G, NK cells, CD8+ NK cells and right amygdala volume was constructed to predict the number of MoCA scores 6 months after the course of rehabilitation (R2=0.57; p<1·10–5; standard error of estimate: 2.93). Conclusion. As a result of this work, the perspectives of assessing the immunological parameters in combination with socio-demographic data and morphometric changes of the brain as potential prognostic markers of the dynamics of cognitive impairment in patients with MCI and pre-MCI after neurorehabilitation has been shown.
- 23 April 2024
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 124 (8) , 81-91
Immunological and neuroanatomic markers of the clinical dynamics of MCI and pre-MCI
Objective. To study the relationship of the parameters of immunity and systemic inflammation with the structural magnetic resonance imaging (MRI) parameters in patients with mild cognitive impairment (MCI) and pre-MCI undergoing neurocognitive rehabilitation to search for candidate markers of its effectiveness. Material and methods. The main group included 49 patients, aged ≥60 years, with MCI and pre-MCI with memory impairment, who underwent a course of neurorehabilitation for 5 weeks. The control group included 19 volunteers of similar age with a total MoCA score of ≥25, who did not have cognitive impairment and immuno-inflammatory disorders. The parameters of cellular and humoral immunity and markers of inflammation were studied, and structural MRI was performed. Results. The content of activated natural killer cells (NK-cells) was increased in MCI and pre-MCI (0.63±0.12% vs. 0.22±0.07% in the control group, p=2.2·10–7). The level of immunoglobulin G (IgG) <12.5 g/l in patients with MCI and pre-MCI with the Montreal Cognitive Assessment Scale (MoCA) score <22 was associated with a decrease in the volume of the right nucleus accumbens (376±35 mm3 in patients with IgG <12.5 g/l (p=0.0013) and 480±44 mm3 at IgG <12.5 g/l, 480±44 mm3 in the control group), as well as with a decrease of the thickness and volume of a number of other cortical zones. A logistic regression model including the level of immunoglobulin G, NK cells, CD8+ NK cells and right amygdala volume was constructed to predict the number of MoCA scores 6 months after the course of rehabilitation (R2=0.57; p<1·10–5; standard error of estimate: 2.93). Conclusion. As a result of this work, the perspectives of assessing the immunological parameters in combination with socio-demographic data and morphometric changes of the brain as potential prognostic markers of the dynamics of cognitive impairment in patients with MCI and pre-MCI after neurorehabilitation has been shown.
- 23 April 2024
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 124 (5) , 102-112
Dynamics of cognitive functions using the rehabilitation program of cognitive training
OBJECTIVE To study the efficiency of the neuropsychological rehabilitation of patients with mild cognitive impairments. MATERIAL AND METHODS The study included 103 elderly people, aged 59 to 88 years, including 90 women and 13 men with subjective complaints of memory loss (ICD-10: F06.70; F06.71; F06.78; F06.79). Participants were divided into experimental group (n=43) and comparison group (n=42). The estimated impact was the rehabilitation program «The psychosocial therapy and neurocognitive rehabilitation of elderly patients with cognitive impairments», within which the principle of complex stimulation of various parameters of the cognitive sphere was used in rehabilitation work with patients in the experimental group in accordance with the «Memory Clinic» program. The study was conducted using randomized, equalized comparison groups, and the principle of «triple-blind» research. Non-parametric statistics (SPSS) methods were used to assess differences. RESULTS A significant difference between the comparison and experimental groups has been identified, primarily in relation to high-level mental processes associated with the function of the third structural-functional block according to A.R. Luria. After the training, the number of correct answers significantly increased (t(42)=–2.67, pt(41)=0.50, p=0.617). The number of false alarms in the experimental group decreased significantly (t(42)=2.13, p=0.039). CONCLUSION The results confirm the leading role of these processes in the hierarchy of mental functions, which suggests that they should primarily be targets of rehabilitation interventions.
- 23 April 2024
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 124 (5) , 102-112
Dynamics of cognitive functions using the rehabilitation program of cognitive training
OBJECTIVE To study the efficiency of the neuropsychological rehabilitation of patients with mild cognitive impairments. MATERIAL AND METHODS The study included 103 elderly people, aged 59 to 88 years, including 90 women and 13 men with subjective complaints of memory loss (ICD-10: F06.70; F06.71; F06.78; F06.79). Participants were divided into experimental group (n=43) and comparison group (n=42). The estimated impact was the rehabilitation program «The psychosocial therapy and neurocognitive rehabilitation of elderly patients with cognitive impairments», within which the principle of complex stimulation of various parameters of the cognitive sphere was used in rehabilitation work with patients in the experimental group in accordance with the «Memory Clinic» program. The study was conducted using randomized, equalized comparison groups, and the principle of «triple-blind» research. Non-parametric statistics (SPSS) methods were used to assess differences. RESULTS A significant difference between the comparison and experimental groups has been identified, primarily in relation to high-level mental processes associated with the function of the third structural-functional block according to A.R. Luria. After the training, the number of correct answers significantly increased (t(42)=–2.67, pt(41)=0.50, p=0.617). The number of false alarms in the experimental group decreased significantly (t(42)=2.13, p=0.039). CONCLUSION The results confirm the leading role of these processes in the hierarchy of mental functions, which suggests that they should primarily be targets of rehabilitation interventions.
- 23 January 2024
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 124 (1) , 121-127
Use of modern classification systems for complex diagnostics of Alzheimer’s disease
Objective. To compare the content of β-amyloid (Aβ) peptides Aβ40, Aβ42, total and threonine phosphorylated 181 tau-protein in cerebrospinal fluid (CSF) of patients with the clinical diagnosis of Alzheimer’s disease (AD). Material and methods. The study was performed on 64 patients with a diagnosis of dementia and MMSE scores of 24 or lower. All patients underwent lumbar puncture. Aβ40, Aβ42, Aβ42/40 ratio, total tau, phosphorylated tau at threonine 181 were determined in the CSF using a multiplex assay according to the manufacturer’s protocol, the concentration was determined in pkg/ml. Results. The preliminary diagnosis of AD was made in 3 patients (5%). As a result of the study of protein content in the CSF, signs of AD were detected in 48 (75%) people. The findings suggest that the diagnosis of AD is made 10—14 times less frequently than it should be according to the World Health Organization data. The discrepancy between clinical diagnosis and laboratory findings is confirmed by our study. Conclusion. Differences in the therapy of dementias and the development of new drugs targeting specific links in the pathogenesis of different types of dementias require accurate and complete diagnosis of dementias, especially AD, as the most common type of dementia.
- 23 January 2024
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 124 (1) , 121-127
Use of modern classification systems for complex diagnostics of Alzheimer’s disease
Objective. To compare the content of β-amyloid (Aβ) peptides Aβ40, Aβ42, total and threonine phosphorylated 181 tau-protein in cerebrospinal fluid (CSF) of patients with the clinical diagnosis of Alzheimer’s disease (AD). Material and methods. The study was performed on 64 patients with a diagnosis of dementia and MMSE scores of 24 or lower. All patients underwent lumbar puncture. Aβ40, Aβ42, Aβ42/40 ratio, total tau, phosphorylated tau at threonine 181 were determined in the CSF using a multiplex assay according to the manufacturer’s protocol, the concentration was determined in pkg/ml. Results. The preliminary diagnosis of AD was made in 3 patients (5%). As a result of the study of protein content in the CSF, signs of AD were detected in 48 (75%) people. The findings suggest that the diagnosis of AD is made 10—14 times less frequently than it should be according to the World Health Organization data. The discrepancy between clinical diagnosis and laboratory findings is confirmed by our study. Conclusion. Differences in the therapy of dementias and the development of new drugs targeting specific links in the pathogenesis of different types of dementias require accurate and complete diagnosis of dementias, especially AD, as the most common type of dementia.
- Open Access
- 29 August 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (17) , 13395
Alteration of Blood Immune Biomarkers in MCI Patients with Different APOE Genotypes after Cognitive Training: A 1 Year Follow-Up Cohort Study
Many studies aim to detect the early phase of dementia. One of the major ways to achieve this is to identify corresponding biomarkers, particularly immune blood biomarkers. The objective of this study was to identify such biomarkers in patients with mild cognitive impairment (MCI) in an experiment that included cognitive training. A group of patients with MCI diagnoses over the age of 65 participated in the study (n = 136). Measurements of cognitive functions (using the Mini-Mental State Examination scale and Montreal Cognitive Assessment) and determination of 27 serum biomarkers were performed twice: on the first visit and on the second visit, one year after the cognitive training. APOE genotypes were also determined. Concentrations of EGF (F = 17; p = 0.00007), Eotaxin (F = 7.17; p = 0.008), GRO (F = 13.42; p = 0.0004), IL-8 (F = 8.16; p = 0.005), MCP-1 (F = 13.46; p = 0.0001) and MDC (F = 5.93; p = 0.016) increased after the cognitive training in MCI patients. All these parameters except IL-8 demonstrated a weak correlation with other immune parameters and were poorly represented in the principal component analysis. Differences in concentrations of IP-10, FGF-2, TGFa and VEGF in patients with MCI were associated with APOE genotype. Therefore, the study identified several immune blood biomarkers that could potentially be associated with changes in cognitive function.
- 29 August 2023
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (17) , 13395
Open AccessAlteration of Blood Immune Biomarkers in MCI Patients with Different APOE Genotypes after Cognitive Training: A 1 Year Follow-Up Cohort Study
Many studies aim to detect the early phase of dementia. One of the major ways to achieve this is to identify corresponding biomarkers, particularly immune blood biomarkers. The objective of this study was to identify such biomarkers in patients with mild cognitive impairment (MCI) in an experiment that included cognitive training. A group of patients with MCI diagnoses over the age of 65 participated in the study (n = 136). Measurements of cognitive functions (using the Mini-Mental State Examination scale and Montreal Cognitive Assessment) and determination of 27 serum biomarkers were performed twice: on the first visit and on the second visit, one year after the cognitive training. APOE genotypes were also determined. Concentrations of EGF (F = 17; p = 0.00007), Eotaxin (F = 7.17; p = 0.008), GRO (F = 13.42; p = 0.0004), IL-8 (F = 8.16; p = 0.005), MCP-1 (F = 13.46; p = 0.0001) and MDC (F = 5.93; p = 0.016) increased after the cognitive training in MCI patients. All these parameters except IL-8 demonstrated a weak correlation with other immune parameters and were poorly represented in the principal component analysis. Differences in concentrations of IP-10, FGF-2, TGFa and VEGF in patients with MCI were associated with APOE genotype. Therefore, the study identified several immune blood biomarkers that could potentially be associated with changes in cognitive function.
- Open Access
- 1 June 2023
- Published by SPb RAACI in Medical Immunology (Russia)
- Vol. 25 (5) , 1233-1240
Levels of chemokines and other inflammatory mediators in patients with mild cognitive impairment undergoing rehabilitation
Alzheimer's disease is the most common neurodegenerative disease in old age. In some cases, it is preceded by mild cognitive impairment (MCI). One of the important components in the pathogenesis of neurodegeneration is chronic neuroinflammation (inflammatory activation of microglia and astrocytes in the brain). Systemic inflammatory response and immune dysregulation may contribute to neuroinflammation. The purpose of this study was to investigate the level of chemokines and other inflammatory mediators in patients with MCI who underwent medical rehabilitation, and to study its associations with the severity of cognitive impairment. The study group included 48 patients with MCI undergoing rehabilitation. Rehabilitation included cognitive therapy, psychotherapy and tasks for unaided performance. Repeated examination was conducted 6 months after the completion of rehabilitation. The control group included 46 healthy volunteers. Multiplex assay was used to determine serum cytokine and chemokine concentrations. Student's t-test was used to assess the significance of differences. Assessment of cognitive functions was performed using international neuropsychological scales. In patients with MCI, we have found an increase in the levels of several cytokines and chemokines (TNFα, CXCL10/IP10, MDC) that regulate systemic inflammation, cellular and humoral mechanisms of adaptive immunity. After the rehabilitation course their levels returned to normal. It was also found that decrease in CCL7 level in the patients before the rehabilitation course is associated with the severity of cognitive impairment. The findings contribute to understanding the role of chemokines in the pathogenesis of MCI, and indicate that their levels can be potential biomarkers of the severity of cognitive impairment. For translation of the findings into clinical practice, their validation in larger studies is needed, as well as assessing the associations between chemokine levels and the severity of cognitive impairment in MCI over long-term follow-up.
- 1 June 2023
- Published by SPb RAACI in Medical Immunology (Russia)
- Vol. 25 (5) , 1233-1240
Open AccessLevels of chemokines and other inflammatory mediators in patients with mild cognitive impairment undergoing rehabilitation
Alzheimer's disease is the most common neurodegenerative disease in old age. In some cases, it is preceded by mild cognitive impairment (MCI). One of the important components in the pathogenesis of neurodegeneration is chronic neuroinflammation (inflammatory activation of microglia and astrocytes in the brain). Systemic inflammatory response and immune dysregulation may contribute to neuroinflammation. The purpose of this study was to investigate the level of chemokines and other inflammatory mediators in patients with MCI who underwent medical rehabilitation, and to study its associations with the severity of cognitive impairment. The study group included 48 patients with MCI undergoing rehabilitation. Rehabilitation included cognitive therapy, psychotherapy and tasks for unaided performance. Repeated examination was conducted 6 months after the completion of rehabilitation. The control group included 46 healthy volunteers. Multiplex assay was used to determine serum cytokine and chemokine concentrations. Student's t-test was used to assess the significance of differences. Assessment of cognitive functions was performed using international neuropsychological scales. In patients with MCI, we have found an increase in the levels of several cytokines and chemokines (TNFα, CXCL10/IP10, MDC) that regulate systemic inflammation, cellular and humoral mechanisms of adaptive immunity. After the rehabilitation course their levels returned to normal. It was also found that decrease in CCL7 level in the patients before the rehabilitation course is associated with the severity of cognitive impairment. The findings contribute to understanding the role of chemokines in the pathogenesis of MCI, and indicate that their levels can be potential biomarkers of the severity of cognitive impairment. For translation of the findings into clinical practice, their validation in larger studies is needed, as well as assessing the associations between chemokine levels and the severity of cognitive impairment in MCI over long-term follow-up.